Interpreting the Complex Landscape of Immune–Tumor Interface

W. Fraser Symmans

doi:10.1158/1078-0432.CCR-21-2208

Interpreting the Complex Landscape of Immune–Tumor Interface

W. Fraser Symmans

Pathology, Anatomical

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Predictive biomarkers for immune therapy must address a complex interface between the immune system and triple-negative breast cancer and still be technically reliable for diagnostic use. Two recent articles describe the assessment of spatial heterogeneity using digital methods that promise to improve the quantification of immune infiltrate or molecular targets.

Original language	English (US)
Pages (from-to)	OF1-OF3
Journal	Clinical Cancer Research
Volume	27
Issue number	20
DOIs	https://doi.org/10.1158/1078-0432.CCR-21-2208
State	Published - Oct 15 2021

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1158/1078-0432.CCR-21-2208

Cite this

@article{ae7d2cd53b7540ff868afadc31a3fe18,

title = "Interpreting the Complex Landscape of Immune–Tumor Interface",

abstract = "Predictive biomarkers for immune therapy must address a complex interface between the immune system and triple-negative breast cancer and still be technically reliable for diagnostic use. Two recent articles describe the assessment of spatial heterogeneity using digital methods that promise to improve the quantification of immune infiltrate or molecular targets.",

author = "Symmans, {W. Fraser}",

note = "Publisher Copyright: {\'O}2021 American Association for Cancer Research",

year = "2021",

month = oct,

day = "15",

doi = "10.1158/1078-0432.CCR-21-2208",

language = "English (US)",

volume = "27",

pages = "OF1--OF3",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "20",

}

TY - JOUR

T1 - Interpreting the Complex Landscape of Immune–Tumor Interface

AU - Symmans, W. Fraser

N1 - Publisher Copyright: Ó2021 American Association for Cancer Research

PY - 2021/10/15

Y1 - 2021/10/15

N2 - Predictive biomarkers for immune therapy must address a complex interface between the immune system and triple-negative breast cancer and still be technically reliable for diagnostic use. Two recent articles describe the assessment of spatial heterogeneity using digital methods that promise to improve the quantification of immune infiltrate or molecular targets.

AB - Predictive biomarkers for immune therapy must address a complex interface between the immune system and triple-negative breast cancer and still be technically reliable for diagnostic use. Two recent articles describe the assessment of spatial heterogeneity using digital methods that promise to improve the quantification of immune infiltrate or molecular targets.

UR - http://www.scopus.com/inward/record.url?scp=85117459411&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85117459411&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-21-2208

DO - 10.1158/1078-0432.CCR-21-2208

M3 - Article

C2 - 34389608

AN - SCOPUS:85117459411

SN - 1078-0432

VL - 27

SP - OF1-OF3

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 20

ER -

Interpreting the Complex Landscape of Immune–Tumor Interface

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this